Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots.
The MICs of echinocandins against Candida isolates with fks mutations are higher than those for wild-type (WT) isolates. However, the MIC ranges for susceptible and mutant populations overlap or are poorly separated. It was recently reported that a greater separation could be achieved in the presence of serum. To more fully explore this possibility, we compared the performances of the reference microdilution methods by using standard and bovine serum albumin (BSA)-supplemented growth medium. Anidulafungin, caspofungin, and micafungin MICs were determined according to EUCAST and CLSI methods and with 50% BSA in the medium for 93 clinical isolates, including Candida albicans (20/10 [number of isolates/number of mutants]), C. glabrata (19/10), C. dubliniensis (2/1), C. krusei (16/3), C. parapsilosis (19), and C. tropicalis (19/4) isolates. Stability of the plates was tested after storage at -80°C for 2 and 6 months, and the performance of two different lots of caspofungin was investigated. The addition of BSA to the medium resulted in higher MICs (1 to 9 2-fold dilution steps) for all isolates and compounds. The increases were greatest for anidulafungin and micafungin and, among WT isolates, for C. parapsilosis. The number of very major errors (VMEs) was reduced (24% [20/84 isolates] versus ≤ 7% [6/84 isolates]) using BSA-supplemented EUCAST medium but not using BSA-supplemented CLSI medium (6% versus 9%). MIC results were unchanged after 6 months of storage of test plates. The two lots of caspofungin yielded identical results. Addition of BSA to the EUCAST medium increases the ability to differentiate between WT isolates and isolates harboring resistance mutations.
Unit of Mycology and Parasitology (43/117), Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. mad@ssi.dk
Maiken Cavling
MC
Arendrup
Juan-Luis
JL
Rodriguez-Tudela
Steven
S
Park
Guillermo
G
Garcia-Effron
Guillaume
G
Delmas
Manuel
M
Cuenca-Estrella
Alicia
A
Gomez-Lopez
David S
DS
Perlin
D000077612:Anidulafungin; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects*; D000077336:Caspofungin; D002417:Cattle; D054714:Echinocandins / Q000494:pharmacology*; D055666:Lipopeptides / Q000494:pharmacology; D000077551:Micafungin; D008826:Microbial Sensitivity Tests; D012710:Serum Albumin, Bovine / Q000494:pharmacology*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D012710:Serum Albumin, Bovine; D000077612:Anidulafungin; D000077336:Caspofungin; D000077551:Micafungin
Pharmacotherapy. 2006 Jun;26(6):877-80
16716141
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12
18443110
J Clin Microbiol. 2010 Nov;48(11):4200-6
20826636
N Engl J Med. 2002 Dec 19;347(25):2020-9
12490683
Antimicrob Agents Chemother. 2010 Jan;54(1):426-39
19884370
J Clin Microbiol. 2008 Jan;46(1):150-6
18032613
Clin Infect Dis. 2007 Oct 1;45(7):883-93
17806055
Antimicrob Agents Chemother. 2008 Feb;52(2):778-81
18070978
J Antimicrob Chemother. 2008 Jan;61(1):219
18024953
Clin Infect Dis. 2009 Jun 15;48(12):1695-703
19441981
Antimicrob Agents Chemother. 2006 Aug;50(8):2892-4
16870797
J Clin Microbiol. 2010 Jul;48(7):2373-80
20421445
J Antimicrob Chemother. 2007 Jun;59(6):1076-83
17468115
Antimicrob Agents Chemother. 2009 Jan;53(1):112-22
18955538
Antimicrob Agents Chemother. 2007 May;51(5):1616-20
17307976
Drug Resist Updat. 2007 Jun;10(3):121-30
17569573
J Clin Microbiol. 2006 May;44(5):1681-5
16672393
Antimicrob Agents Chemother. 2007 Nov;51(11):4214-6
17785512
Clin Microbiol Infect. 2008 Apr;14(4):398-405
18190574
J Clin Microbiol. 2007 Mar;45(3):698-706
17202279
Antimicrob Agents Chemother. 2009 Mar;53(3):1185-93
19104024
Clin Infect Dis. 2006 Jul 1;43(1):25-31
16758414
J Antimicrob Chemother. 2006 Apr;57(4):705-8
16464893
Antimicrob Agents Chemother. 2007 Jun;51(6):2253-6
17420211
Lancet. 2007 May 5;369(9572):1519-1527
17482982
J Clin Microbiol. 2002 Oct;40(10):3841-4
12354895
Clin Microbiol Rev. 2007 Jan;20(1):133-63
17223626
Infection. 2002 Oct;30(5):286-91
12382088
J Antimicrob Chemother. 2005 Sep;56(3):532-7
16040623
J Clin Microbiol. 2004 Apr;42(4):1519-27
15070998
Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54
14506023
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):317-22
15029512
Antimicrob Agents Chemother. 2008 Sep;52(9):3092-8
18591282
Antimicrob Agents Chemother. 2005 Aug;49(8):3264-73
16048935
J Clin Microbiol. 2008 Aug;46(8):2620-9
18579718
Antimicrob Agents Chemother. 2010 Jul;54(7):3056-7
20479199